NO305248B1 - Antimigrene 1,2,5-tiadiazolderivater av indolylalkylpyridinyl- og -pyrimidinylpiperaziner og anvendelse derav, samt farmas°ytiske preparater inneholdende dem - Google Patents
Antimigrene 1,2,5-tiadiazolderivater av indolylalkylpyridinyl- og -pyrimidinylpiperaziner og anvendelse derav, samt farmas°ytiske preparater inneholdende demInfo
- Publication number
- NO305248B1 NO305248B1 NO960699A NO960699A NO305248B1 NO 305248 B1 NO305248 B1 NO 305248B1 NO 960699 A NO960699 A NO 960699A NO 960699 A NO960699 A NO 960699A NO 305248 B1 NO305248 B1 NO 305248B1
- Authority
- NO
- Norway
- Prior art keywords
- pyrimidinylpiperazines
- indolylalkylpyridinyl
- migraine
- well
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/396,825 US5618816A (en) | 1995-03-02 | 1995-03-02 | Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines |
Publications (3)
Publication Number | Publication Date |
---|---|
NO960699D0 NO960699D0 (no) | 1996-02-22 |
NO960699L NO960699L (no) | 1996-09-03 |
NO305248B1 true NO305248B1 (no) | 1999-04-26 |
Family
ID=23568771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO960699A NO305248B1 (no) | 1995-03-02 | 1996-02-22 | Antimigrene 1,2,5-tiadiazolderivater av indolylalkylpyridinyl- og -pyrimidinylpiperaziner og anvendelse derav, samt farmas°ytiske preparater inneholdende dem |
Country Status (17)
Country | Link |
---|---|
US (1) | US5618816A (ru) |
EP (1) | EP0729958A2 (ru) |
JP (1) | JPH08253479A (ru) |
KR (1) | KR960034200A (ru) |
CN (1) | CN1063177C (ru) |
AR (1) | AR002281A1 (ru) |
AU (1) | AU707770B2 (ru) |
CA (1) | CA2169804A1 (ru) |
CZ (1) | CZ46896A3 (ru) |
HU (1) | HUP9600498A3 (ru) |
IL (1) | IL117224A (ru) |
NO (1) | NO305248B1 (ru) |
NZ (1) | NZ286090A (ru) |
PL (1) | PL313022A1 (ru) |
RU (1) | RU2165420C2 (ru) |
TW (1) | TW331558B (ru) |
ZA (1) | ZA961392B (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU694226B2 (en) * | 1994-05-19 | 1998-07-16 | Merck Sharp & Dohme Limited | Piperazine, piperidine and tetrahydropyridine derivatives ofindol-3-ylalkyl as 5-HT1D-alpha agonists |
GB9415575D0 (en) * | 1994-08-02 | 1994-09-21 | Merck Sharp & Dohme | Therapeutic agents |
GB9501865D0 (en) * | 1995-01-31 | 1995-03-22 | Merck Sharp & Dohme | Therapeutic agents |
US5872145A (en) * | 1996-08-16 | 1999-02-16 | Pozen, Inc. | Formulation of 5-HT agonist and NSAID for treatment of migraine |
US6586458B1 (en) | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
US7332183B2 (en) * | 2002-12-26 | 2008-02-19 | Pozen Inc. | Multilayer dosage forms containing NSAIDs and triptans |
WO2004110492A2 (en) * | 2003-06-06 | 2004-12-23 | Glaxo Group Limited | Composition comprising triptans and nsaids |
EP3027607B1 (en) | 2013-07-29 | 2020-08-26 | Sunshine Lake Pharma Co., Ltd. | Substituted heteroaryl compounds and methods of use thereof |
US10316025B2 (en) | 2015-06-03 | 2019-06-11 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3468882A (en) * | 1966-10-07 | 1969-09-23 | Sterling Drug Inc | Phenylhydrazone derivatives as intermediates for preparing indoles |
NL189197C (nl) * | 1979-09-04 | 1993-02-01 | Bristol Myers Squibb Co | 3,4-digesubstitueerde-1,2,5-thiadiazool-1-oxiden en 1,1-dioxiden, bereiding daarvan alsmede farmaceutische preparaten. |
US4600779A (en) * | 1982-03-29 | 1986-07-15 | Bristol-Myers Company | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
IT1170387B (it) * | 1982-06-07 | 1987-06-03 | Glaxo Group Ltd | Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono |
US4440933A (en) * | 1983-03-16 | 1984-04-03 | Bristol-Myers Company | Process for preparing 1,2,5-thiadiazoles |
GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
US4954502A (en) * | 1988-06-10 | 1990-09-04 | Bristol-Myers Squibb Company | 1-indolyalkyl-4-(substituted-pyridinyl)piperazines |
FR2635104B1 (fr) * | 1988-08-03 | 1992-04-30 | Synthelabo | Derives d'indolone, leur preparation et leur application en therapeutique |
FR2672052B1 (fr) * | 1991-01-28 | 1995-05-24 | Esteve Labor Dr | Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments. |
CA2043709C (en) * | 1990-06-29 | 2002-01-22 | David W. Smith | Antimigraine alkoxypyrimidine derivatives |
US5077293A (en) * | 1990-06-29 | 1991-12-31 | Bristol-Myers Squibb Co. | 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines |
DE4101686A1 (de) * | 1991-01-22 | 1992-07-23 | Merck Patent Gmbh | Indolderivate |
CA2084531A1 (en) * | 1991-12-19 | 1993-06-20 | David W. Smith | Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines |
CA2130078A1 (en) * | 1993-09-16 | 1995-03-17 | Jonas A. Gylys | Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines |
GB9410031D0 (en) * | 1994-05-19 | 1994-07-06 | Merck Sharp & Dohme | Therapeutic agents |
AU694226B2 (en) * | 1994-05-19 | 1998-07-16 | Merck Sharp & Dohme Limited | Piperazine, piperidine and tetrahydropyridine derivatives ofindol-3-ylalkyl as 5-HT1D-alpha agonists |
GB9415575D0 (en) * | 1994-08-02 | 1994-09-21 | Merck Sharp & Dohme | Therapeutic agents |
-
1995
- 1995-03-02 US US08/396,825 patent/US5618816A/en not_active Expired - Lifetime
-
1996
- 1996-02-03 TW TW085101358A patent/TW331558B/zh active
- 1996-02-16 CZ CZ96468A patent/CZ46896A3/cs unknown
- 1996-02-19 CA CA002169804A patent/CA2169804A1/en not_active Abandoned
- 1996-02-21 ZA ZA9601392A patent/ZA961392B/xx unknown
- 1996-02-22 IL IL11722496A patent/IL117224A/xx not_active IP Right Cessation
- 1996-02-22 NO NO960699A patent/NO305248B1/no not_active IP Right Cessation
- 1996-02-28 NZ NZ286090A patent/NZ286090A/en unknown
- 1996-02-29 HU HU9600498A patent/HUP9600498A3/hu unknown
- 1996-02-29 KR KR1019960005354A patent/KR960034200A/ko not_active Application Discontinuation
- 1996-03-01 CN CN96105542A patent/CN1063177C/zh not_active Expired - Fee Related
- 1996-03-01 RU RU96103685/04A patent/RU2165420C2/ru not_active IP Right Cessation
- 1996-03-01 PL PL96313022A patent/PL313022A1/xx unknown
- 1996-03-01 AR ARP960101598A patent/AR002281A1/es unknown
- 1996-03-01 JP JP8044338A patent/JPH08253479A/ja active Pending
- 1996-03-01 AU AU45819/96A patent/AU707770B2/en not_active Ceased
- 1996-03-01 EP EP96103214A patent/EP0729958A2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
NZ286090A (en) | 1997-12-19 |
HUP9600498A2 (en) | 1997-10-28 |
HU9600498D0 (en) | 1996-04-29 |
TW331558B (en) | 1998-05-11 |
CN1138042A (zh) | 1996-12-18 |
ZA961392B (en) | 1997-08-21 |
AR002281A1 (es) | 1998-03-11 |
CN1063177C (zh) | 2001-03-14 |
JPH08253479A (ja) | 1996-10-01 |
IL117224A0 (en) | 1996-06-18 |
HUP9600498A3 (en) | 1998-10-28 |
EP0729958A2 (en) | 1996-09-04 |
IL117224A (en) | 2000-06-29 |
CA2169804A1 (en) | 1996-09-03 |
EP0729958A3 (ru) | 1996-10-02 |
AU4581996A (en) | 1996-09-12 |
AU707770B2 (en) | 1999-07-22 |
KR960034200A (ko) | 1996-10-22 |
RU2165420C2 (ru) | 2001-04-20 |
NO960699L (no) | 1996-09-03 |
PL313022A1 (en) | 1996-09-16 |
US5618816A (en) | 1997-04-08 |
NO960699D0 (no) | 1996-02-22 |
CZ46896A3 (en) | 1996-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO305952B1 (no) | 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater | |
NO944700D0 (no) | Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene | |
NO303638B1 (no) | Kondenserte indolderivater, farmas°ytiske preparater inneholdende disse og anvendelse av derivatene | |
DK0432040T3 (da) | Heterocykliske acylaminothiazolderivater, deres fremstilling samt farmaceutiske midler indeholdende dem | |
NO2009028I1 (no) | Kinazolin-derivater, anvendelse og fremstilling derav, samt farmasøytisk preparat | |
AU7545894A (en) | Carbamate derivative and medicine containing the same | |
NO305903B1 (no) | Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
DK0562583T3 (da) | Hidtil ukendte alkylendiammoniumdiclavulanatderivater, fremgangsmåde til fremstilling deraf samt anvendelse deraf | |
AU9049391A (en) | 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity | |
NO305248B1 (no) | Antimigrene 1,2,5-tiadiazolderivater av indolylalkylpyridinyl- og -pyrimidinylpiperaziner og anvendelse derav, samt farmas°ytiske preparater inneholdende dem | |
BR9408026A (pt) | Derivados de pirazol e herbicidas contendo os mesmos | |
NO941374D0 (no) | 5-acylamino-1,2,4-tiadiazoler, fremstilling derav og farmasöytiske blandinger inneholdende dem | |
NO893826L (no) | Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater. | |
NO924990D0 (no) | Substituerte pyridin-n-oksyder, fremgangsmaater for fremstilling av dem, samt anvendelser av dem | |
NO308251B1 (no) | Karbohydratderivater, farmasøytisk blanding inneholdende karbohydratderivater samt anvendelse av samme | |
NO931400D0 (no) | Derivater av adipogeneseinhiberende faktor, samt fremstilling og anvendelse derav | |
DK439589A (da) | Fluorsubstituerede 4'-demethylepipodophyllotoksinderivater samt farmaceutiske praeparater indeholdende samme | |
HUP9800631A3 (en) | 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions | |
NO903004D0 (no) | Fremgangsmaate for hvittoning av papirbestrykningsmasser samt hvittoningspreparater for fremgangsmaaten. | |
NO305750B1 (no) | Substituerte benzensulfonylureaer og deres anvendelse for fremstilling av farmas°ytiske preparater samt farmas°ytiske preparater inneholdende forbindelsene | |
DK87687D0 (da) | 1,6-naphthyridinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende dem | |
NO305795B1 (no) | Substituerte benzensulfonylurinstoffer og -tiourinstoffer, og anvendelse i farmas°ytiske preparater pÕ basis av disse forbindelsene samt legemidler inneholdende forbindelsene | |
NO891985D0 (no) | Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater. | |
NO306212B1 (no) | Oligosakkarid selektivt for 1,3-L-fucosyltransferase samt anvendelse av samme | |
NO894516L (no) | Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |